Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)
Clinical trial NCT02115321 · COMPLETED
Trial details
- NCT number
- NCT02115321
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-09
- Primary completion
- 2015-03-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.